A Parallel Group Treatment, Phase 2a, Double-blind, Two-arm Study to Investigate the Efficacy and Safety of Farudodstat Tablets Compared with its Placebo in Male or Female Alopecia Areata Participants Aged 18 Years and Older with 50% or Greater Scalp Hai
|Effective start/end date||3/10/23 → 3/31/28|
- ASLAN PHARMACEUTICALS (USA) INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.